by | Apr 12, 2024 | Publications
Cancer. 2024 May 1;130(9):1548. doi: 10.1002/cncr.35296. NO ABSTRACT PMID:38604981 | DOI:10.1002/cncr.35296
by | Apr 12, 2024 | Publications
Cancer. 2024 May 1;130(9):1546-1547. doi: 10.1002/cncr.35294. NO ABSTRACT PMID:38604987 | DOI:10.1002/cncr.35294
by | Apr 12, 2024 | Publications
Cureus. 2024 Mar 12;16(3):e56010. doi: 10.7759/cureus.56010. eCollection 2024 Mar. ABSTRACT Multiple myeloma is a disease of the plasma cells of the bone marrow, resulting in the proliferation and release of the monoclonal protein, which further causes end-organ...
by | Apr 11, 2024 | Publications
Blood Adv. 2024 Apr 11:bloodadvances.2023011463. doi: 10.1182/bloodadvances.2023011463. Online ahead of print. ABSTRACT Although most patients with multiple myeloma respond to treatment initially, therapy resistance develops almost invariably and only a subset of...
by | Apr 11, 2024 | Publications
Cancer Res Commun. 2024 Apr 10. doi: 10.1158/2767-9764.CRC-23-0411. Online ahead of print. ABSTRACT Multiple myeloma involves early dissemination of malignant plasma cells across the bone marrow; however, the initial steps of dissemination remain unclear. Human bone...
by | Apr 11, 2024 | Publications
Ann Med. 2024 Dec;56(1):2338604. doi: 10.1080/07853890.2024.2338604. Epub 2024 Apr 10. ABSTRACT BACKGROUND: Circulating plasma cells (CPCs) are defined by the presence of peripheral blood clonal plasma cells, which would contribute to the progression and dissemination...